POMC and posterior cortical atrophy: In PCa patients, glucocorticoids are used in the alleviation of therapy-related side effects, and in the compensation of the abiraterone-induced reduction in serum cortisol and to block the compensatory increase in the adrenocorticotropic hormone (5,9).